๐Ÿ“Š This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vascular Insights

1.1 - Company Overview

Vascular Insights Logo

Vascular Insights

Headquarter: United States
Founded: 20XX๐Ÿ”’
Employees: 100-500๐Ÿ”’
๐ŸŒ Website

Company description

  • Provider of medical devices for the minimally invasive treatment of peripheral vascular disease; engages in the design, development, manufacture and marketing of such devices and is the legal manufacturer of ClariVeinยฎ, a specialty infusion catheter with a rotating tip for controlled 360-degree dispersion of agents.

Products and services

๐Ÿ”’

Key contacts

๐Ÿ”’
๐Ÿ”’

Financial details

๐Ÿ”’

1.2 - Competitors and similar companies to Vascular Insights

CardioDynamics Logo

CardioDynamics

HQ: United States Website
  • Description: Provider of noninvasive impedance cardiography diagnostic and monitoring devices and proprietary ICG sensors, including BioZ Dx, BioZ ICG Monitor, BioZ ICG Module, BioZtect sensors, Niccomo and Cardioscreen monitor, and Rheoscreen measurement devices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full CardioDynamics company profile โ†’
Cardiol Therapeutics Logo

Cardiol Therapeutics

HQ: Canada Website
  • Description: Provider of cannabidiol-based therapies for heart disease, including CardiolRx, an oral solution in clinical development to inhibit inflammatory pathways; CRD-38, a subcutaneous formulation for heart failure aiming to improve pharmacokinetics and therapeutic efficacy; and Phase II studies MAvERIC-Pilot (recurrent pericarditis) and ARCHER (acute myocarditis) evaluating safety, tolerability, efficacy, and impact on myocardial recovery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Cardiol Therapeutics company profile โ†’
NeoChord Logo

NeoChord

HQ: United States Website
  • Description: Provider of devices and services for mitral valve repair on a beating heart, including the NeoChord DS1000 System for echo-guided restoration of damaged mitral valve chords through a small incision; NeoChord ConsultConnect and ConnectCARD consultation services for delivery of artificial chordae tendineae to aid treatment of mitral insufficiency; and the Transcatheter Transseptal NeoChord NeXuS for MRI safety under specific conditions post-treatment with NeoChord devices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full NeoChord company profile โ†’
Hyloris Pharmaceuticals Logo

Hyloris Pharmaceuticals

HQ: Belgium Website
  • Description: Provider of specialty pharmaceutical therapies, including Sotalol IV for atrial fibrillation (developed with AltaThera), Maxigesic IV, a non-opioid analgesic for post-operative pain combining paracetamol and ibuprofen sodium dihydrate (developed with AFT Pharmaceuticals), and Podofilox Gel 0.5% for anogenital warts, equivalent to Condylox.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Hyloris Pharmaceuticals company profile โ†’
Recovery Force Logo

Recovery Force

HQ: United States Website
  • Description: Provider of MORPH, an on-body pre recovery and performance enhancement system, developed and manufactured by Recovery Force.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Recovery Force company profile โ†’
๐Ÿ”’

2.M&A buyers

2.1 Potential strategic acquirers in the sector

๐Ÿ”’
๐Ÿ”’
๐Ÿ”’
๐Ÿ”’ View all strategic buyers with complete profiles
Start Free Trial โ†’

2.2 - Strategic buyer groups for Vascular Insights

๐Ÿ”’

Buyer group 1: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”’

Buyer group 2: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”’

Buyer group 3: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial โ†’

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vascular Insights

2.2 - Growth funds investing in similar companies to Vascular Insights

๐Ÿ”’ View all growth equity funds with complete profiles
Start Free Trial โ†’

4 - Top valuation comps for Vascular Insights

4.2 - Public trading comparable groups for Vascular Insights

๐Ÿ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial โ†’

4.3 - M&A Transactions similar to Vascular Insights

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
๐Ÿ”’ View all M&A transactions with complete deal terms
Request Free Trial Now โ†’

Frequently Asked Questions

About Vascular Insights

What does Vascular Insights do?

Vascular Insights is a provider of medical devices for the minimally invasive treatment of peripheral vascular disease; engages in the design, development, manufacture and marketing of such devices and is the legal manufacturer of ClariVeinยฎ, a specialty infusion catheter with a rotating tip for controlled 360-degree dispersion of agents.

Who are Vascular Insights's competitors?

Vascular Insights's competitors and similar companies include CardioDynamics, Cardiol Therapeutics, NeoChord, Hyloris Pharmaceuticals, and Recovery Force.

Where is Vascular Insights headquartered?

Vascular Insights is headquartered in United States.

How many employees does Vascular Insights have?

Vascular Insights has 1,000 employees ๐Ÿ”’.

When was Vascular Insights founded?

Vascular Insights was founded in 2010 ๐Ÿ”’.

What sector and industry vertical is Vascular Insights in?

Vascular Insights is in the Enterprise Software ๐Ÿ”’ sector and industry

M&A Buyers & Acquirers for Vascular Insights

Who are the top strategic acquirers in Vascular Insights's sector and industry

Top strategic M&A buyers and acquirers in Vascular Insights's sector include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Which M&A buyer groups are most relevant for Vascular Insights?

Top strategic M&A buyers groups and sectors for Vascular Insights include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ , โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Financial Investors investing in Vascular Insights's sector and industry vertical

Which are the top PE firms investing in Vascular Insights's sector and industry vertical?

Top PE firms investing in Vascular Insights's sector and industry vertical include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Who are the top buyout funds acquiring in Vascular Insights's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vascular Insights's sector and industry vertical include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Who are the top growth equity funds investing in companies in Vascular Insights's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vascular Insights include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Valuation benchmarks of companies in Vascular Insights's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vascular Insights?

The key public trading comparables and valuation benchmarks for Vascular Insights include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Which are the key trading comparable groups for Vascular Insights for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vascular Insights with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vascular Insights's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vascular Insights with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vascular Insights's' sector and industry vertical?

Access recent funding rounds and capital raises in Vascular Insights's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vascular Insights

Launch login modal Launch register modal